Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells

Chemico-Biological Interactions

Volumn 180, Issue 1, 2009, Pages 61-68

  Lin, Tseng Hsi ^a,b   Lu, Fung Jou ^a   Yin, Yu Fang ^a   Tseng, Tsui Hwa ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Arsenic trioxide; Esculetin; Leukemia; Reduced glutathione

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ARSENIC TRIOXIDE; CASPASE; CYTOCHROME C; ESCULETIN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN U937; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYSOSOME; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN CONFORMATION; PROTEIN SECRETION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; APOPTOSIS; ARSENICALS; BLOTTING, WESTERN; CELL SURVIVAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LEUKEMIA; OXIDES; U937 CELLS; UMBELLIFERONES;

EID: 67349157539     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.01.011     Document Type: Article

References (37)

1. Tallman M.S., Nabhan C., Feusner J.H., and Rowe J.M. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 99 (2002) 759-767
2. Murgo A.J. Clinical trials of arsenic trioxide in hematologic and solid tumor: overview of the National Cancer Institute Cooperative Research and Development Studies. The Oncologist 6 Suppl. 2 (2001) 22-28
3. Huang S.Y., Chang C.S., Tang J.L., Tien H.F., Kuo T.L., Huang S.F., Yao Y.T., Chou W.C., Chung C.Y., Wang C.H., Shen M.C., and Chen Y.C. Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. Br. J. Haematol. 103 (1998) 1092-1095
4. Dai J., Weinberg R.S., Waxman S., and Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93 (1999) 268-277
5. Davison K., Cote S., Mader S., and Miller W.H. Glutathone depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines. Leukemia 17 (2003) 931-940
6. Lawen A. Apoptosis-an introduction. Bioessays 25 (2003) 888-896
7. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
8. Guicciardi M.E., Leist M., and Gores G.J. Lysosomes in cell death. Oncogene 23 (2004) 2881-2890
9. Desagher S.A., Nichols O.-S.A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B., and Martinou J.C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144 (1999) 891-901
10. Milella M., Precupanu C.M., Gregorj C., Ricciardi M.R., Petrucci M.T., Kornblau S.M., Tafuri A., and Andreeff M. Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects. Curr. Pharm. Des. 11 (2005) 2779-2795
11. 2+-dependent production of superoxide. Int. J. Cancer 92 (2001) 518-526
12. Lunghi P., Tabillo A., Lo-Coco F., Pelicci P.G., and Bonati A. Arsenic trioxide (ATO) and MEK1, inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells. Leukemia 19 (2005) 234-244
13. 2-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. J. Cell Physiol. 209 (2006) 1006-1015
14. Chang W.S., Lin C.C., Chuang S.C., and Chiang H.C. Superoxide anion scavenging effect of coumarins. Am. J. Chin. Med. 24 (1996) 11-17
15. Yue J., and Xu J. Chemical components from Ceratostigma willmottianum. J. Nat. Prod. 60 (1997) 1031-1033
16. Kemal C., Louis-Flamerg P., Krupinski-Olsen R., and Shorter A.L. Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activity. Biochemistry 26 (1987) 7064-7072
17. Neichi T., Koshihara Y., and Murota S.I. Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta 753 (1983) 130-132
18. Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., and Thornes R.D. The pharmacology, metabolism, analysis and applications of coumarin and coumarin-related compounds. Drug Metab. Rev. 22 (1990) 503-529
19. Okada Y., Miyauchi N., Suzuki K., and Kobayashi T. Search for naturally occurring substances to prevent the complications of diabetes: II. Inhibitory effect of coumarin and flavonoid derivatieves on bovine lens aldose reductase and rabbit platelet aggregation. Chem. Pharm. Bull. 43 (1995) 1385-1387
20. Matsunaga K., Yoshimi N., Yamada Y., Shimizu M., Kawabata K., Ozawa Y., Hara A., and Mori H. Inhibitory effects of Nabumetone, a cycloxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn. J. Cancer Res. 89 (1998) 496-501
21. Hecht S.S., Kenney P.M., Wang M., Trushin N., Agarwal S., Rao A.V., and Upadhyaya P. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett. 137 (1999) 123-130
22. Lin W.L., Wang C.J., Tsai Y.Y., Liu C.L., Hwang J.M., and Tseng T.H. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch. Toxicol. 74 (2000) 467-472
23. Paya M., Halliwell B., and Hoult J.R.S. Interactions of a series of coumarins with reactions oxygen species. Biochem. Pharmacol. 44 (1992) 205-214
24. Noguchi M., Earashi M., Minami M., Miyazaki I., Tanaka M., and Sasaki T. Effects of piroxicam and esculetin on the MDA-MB-231 human. Prostaglandins Leukot. Essent. Fatty Acids 53 (1995) 325-329
25. Pan S.L., Huang Y.W., Guh J.H., Chang Y.L., Peng C.Y., and Teng C.M. Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats. Biochem. Pharmacol. 65 (2003) 1897-1905
26. Hofmanova J., Kozubik A., Kusek L., and Pachemik J. Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells. Eur. J. Pharmacol. 350 (1998) 273-284
27. Chu C.Y., Tsai Y.Y., Wang C.J., Lin W.L., and Tseng T.H. Induction of apoptosis by esculetin in human leukemia cells. Eur. J. Pharmacol. 416 (2001) 25-32
28. Wang C.J., Hsieh Y.J., Chu C.Y., Lin Y.L., and Tseng T.H. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 183 (2002) 163-168
29. Kuo H.C., Lee H.J., Hu C.C., Shun H.I., and Tseng T.H. Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol. Appl. Pharmacol. 210 (2006) 55-62
30. Fernandez-Checa J.C., and Kaplowitz N. The use of monochlorobimane to determine hepatic GSH levels and synthesis. Anal. Biochem. 190 (1990) 212-219
31. Roucou X., Montessuit S., Antonsson B., and Martinou J.C. Bax oligomeriztion in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem. J. 368 (2002) 915-921
32. Blomgran R., Zheng L., and Stendahl O. Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J. Leukoc. Biol. 81 (2007) 1221-1223
33. Conus S., Perozzo R., Reinheckel T., Peters C., Scapozza L., Yousefi S., and Simon H.U. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. JCB 180 (2008) i1-i14
34. Reed J.C., Jurgensmeier J.M., and Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1366 (1998) 127-137
35. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., Ellerby L.M., Bredesen D., Freeze H., Abrahamson M., Bromme D., Krajewski S., Reed J.C., Yin X.M., Turk V., and Salvesen G.S. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276 (2001) 3149-3157
36. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C.P., Kaufmann S.H., and Gores G.J. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106 (2000) 1127-1137
37. Leung K.N., Leung P.Y., Kong L.P., and Leung P.K. Immunomodulatory effects of esculetin (6,7-dihydroxycoumarin) on murine lymphocytes and peritoneal macrophages. Cell Mol. Immunol. 2 (2005) 181-188